标题
Problems of glioblastoma multiforme drug resistance
作者
关键词
glioblastoma, temozolomide, drug resistance, <em class=EmphasisTypeItalic >YB</em>-1 gene, microRNA
出版物
BIOCHEMISTRY-MOSCOW
Volume 81, Issue 2, Pages 91-100
出版商
Pleiades Publishing Ltd
发表日期
2016-02-15
DOI
10.1134/s0006297916020036
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A major role for microRNAs in glioblastoma cancer stem-like cells
- (2015) Hong Wei Yang et al. ARCHIVES OF PHARMACAL RESEARCH
- EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma
- (2015) Junxia Zhang et al. CANCER LETTERS
- Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression
- (2015) Kristen M. Turner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glioblastoma: Molecular Pathways, Stem Cells and Therapeutic Targets
- (2015) Meena Jhanwar-Uniyal et al. Cancers
- Epigenetic Regulation of miRNA-211 by MMP-9 Governs Glioma Cell Apoptosis, Chemosensitivity and Radiosensitivity
- (2015) Swapna Asuthkar et al. Oncotarget
- Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis
- (2015) Daniela Loetsch et al. Oncotarget
- Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1)
- (2015) Kristen M. Reipas et al. Oncotarget
- MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis
- (2015) Wei Yan et al. Oncotarget
- Differential expression of miR200a-3p and miR21 in grade II–III and grade IV gliomas
- (2014) Yolande Berthois et al. CANCER BIOLOGY & THERAPY
- Current and Investigational Drug Strategies for Glioblastoma
- (2014) M. Ajaz et al. CLINICAL ONCOLOGY
- Maternal Embryonic Leucine Zipper Kinase: Key Kinase for Stem Cell Phenotype in Glioma and Other Cancers
- (2014) R. Ganguly et al. MOLECULAR CANCER THERAPEUTICS
- NEO212, Temozolomide Conjugated to Perillyl Alcohol, Is a Novel Drug for Effective Treatment of a Broad Range of Temozolomide-Resistant Gliomas
- (2014) H.-Y. Cho et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNAs in cancer: Glioblastoma and glioblastoma cancer stem cells
- (2014) Jeffrey V. Brower et al. NEUROCHEMISTRY INTERNATIONAL
- Regulation and Role of EZH2 in Cancer
- (2014) Hirohito Yamaguchi et al. Cancer Research and Treatment
- Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme
- (2013) Moritz C Oberstadt et al. BMC CANCER
- Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells
- (2013) V Martín et al. BRITISH JOURNAL OF CANCER
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Long-Term Survival in Primary Glioblastoma With Versus Without Isocitrate Dehydrogenase Mutations
- (2013) C. Hartmann et al. CLINICAL CANCER RESEARCH
- Drug Review: Safety and Efficacy of Bevacizumab for Glioblastoma and Other Brain Tumors
- (2013) Yoshitaka Narita JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Blood–brain barrier structure and function and the challenges for CNS drug delivery
- (2013) N. Joan Abbott JOURNAL OF INHERITED METABOLIC DISEASE
- Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/ -catenin pathway
- (2013) C. Riganti et al. NEURO-ONCOLOGY
- MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells
- (2013) Kaushal Joshi et al. STEM CELLS
- Association of Nuclear YB-1 Localization With Lung Resistance-related Protein and Epidermal Growth Factor Receptor Expression in Lung Cancer
- (2012) Akira Hyogotani et al. Clinical Lung Cancer
- YB-1 Protein and Multidrug Resistance of Tumor Cells
- (2012) Alla Stavrovskaya et al. Current Signal Transduction Therapy
- O6-Methylguanine-Methyltransferase (MGMT) Promoter Methylation Status in Glioma Stem-Like Cells is Correlated to Temozolomide Sensitivity Under Differentiation-Promoting Conditions
- (2012) Claire Villalva et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma
- (2012) Qiong Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression
- (2012) W. Zhang et al. NEURO-ONCOLOGY
- Role of P-glycoprotein in evolution of populations of chronic myeloid leukemia cells treated with imatinib
- (2011) T. P. Stromskaya et al. BIOCHEMISTRY-MOSCOW
- YB-1 Bridges Neural Stem Cells and Brain Tumor-Initiating Cells via Its Roles in Differentiation and Cell Growth
- (2011) A. Fotovati et al. CANCER RESEARCH
- ABC Transporters in the CNS – An Inventory
- (2011) A. M.S. Hartz et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implications
- (2011) Jiri Sana et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies
- (2011) K. Masui et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Certain Imidazotetrazines Escape O6-Methylguanine-DNA Methyltransferase and Mismatch Repair
- (2011) Jihong Zhang et al. ONCOLOGY
- Temozolomide: Mechanisms of Action, Repair and Resistance
- (2011) Jihong Zhang et al. Current Molecular Pharmacology
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- miR-195, miR-455-3p and miR-10a∗ are implicated in acquired temozolomide resistance in glioblastoma multiforme cells
- (2010) Kenta Ujifuku et al. CANCER LETTERS
- Regulation of P-glycoprotein and other ABC drug transporters at the blood–brain barrier
- (2010) David S. Miller TRENDS IN PHARMACOLOGICAL SCIENCES
- Blinded by the Light: The Growing Complexity of p53
- (2009) Karen H. Vousden et al. CELL
- PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells
- (2009) Anne-Marie Bleau et al. Cell Stem Cell
- Inhibition of Y-box binding protein-1 slows the growth of glioblastoma multiforme and sensitizes to temozolomide independent O6-methylguanine-DNA methyltransferase
- (2009) Y. Gao et al. MOLECULAR CANCER THERAPEUTICS
- A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients
- (2008) M. Schaich et al. ANNALS OF ONCOLOGY
- Transport proteins of the ABC family and multidrug resistance of tumor cells
- (2008) A. A. Stavrovskaya et al. BIOCHEMISTRY-MOSCOW
- Vaults and the major vault protein: Novel roles in signal pathway regulation and immunity
- (2008) W. Berger et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators
- (2008) G. Gabriely et al. MOLECULAR AND CELLULAR BIOLOGY
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now